Univariable HR (95% CI) | p-value | |
Age at cancer diagnosis years | 1.03 (0.96–1.09) | 0.43 |
Male sex % | 0.91 (0.35–2.61) | 0.53 |
Smoking pack-years | 1.01 (0.98–1.02) | 0.51 |
Finger clubbing | 1.15 (0.40–2.86) | 0.78 |
Home oxygen use | 1.32 (0.52–3.57) | 0.56 |
RVSP mmHg | 1.03 (0.99–23.97) | 0.05 |
FVC % pred | 0.98 (0.95–1.01) | 0.16 |
FEV1 % pred | 0.99 (0.97–1.02) | 0.39 |
DLCO % pred | 0.97 (0.93–1.00) | 0.14 |
Presence of honeycombing | 3.03 (1.16–7.91) | 0.02 |
Adenocarcinoma versus others | 1.95 (0.72–4.81) | 0.17 |
Stage at presentation (late or nonresectable (stage III and IV, with small cell) versus potentially resectable NSCLC (stages I and II)) | 4.77 (1.8–14.94) | 0.001 |
Surgical resection performed | 0.29 (0.09–0.87) | 0.02 |
n=26. Bold type represents statistical significance. HR: hazard ratio; RVSP: right ventricular systolic pressure; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of the lung for carbon monoxide; NSCLC: nonsmall cell lung cancer.